Page 8 - Flipbook

Program Objectives

• Evaluate the evolving standard of care in the management

of metastatic renal cell carcinoma (mRCC)

• Reflect on the sequencing of treatments in a changing

landscape and how

this may impact decisions in the first-line setting

• Assess how previous treatment and patient characteristics

impact decision-making

8